Jyotsna Fuloria

Ochsner Health Center - BluebonnetBaton Rouge, Louisiana - 70809 (225-761-5200) |
- CLINICAL TRIALS 9
- CONDITIONS20
- INTERVENTIONS24
- SINCE2005

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Acute Pain Caused by Paclitaxel in Patients With Cancer
February 2009 - April 2011

Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013

Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
March 2005 - June 2015

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
February 2010 - September 2011

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
April 2009 - August 2011

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Liver Neoplasms
Carcinoma, Hepatocellular
Bone Neoplasms
Bone Marrow Diseases
Nausea
Vomiting
Neurotoxicity Syndromes
Colorectal Neoplasms
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Osteonecrosis
Gabapentin
Placebo
Laboratory Biomarker Analysis
Zoledronic Acid
Questionnaire Administration
Celecoxib
Assessment Of Therapy Complications
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Polymorphism Analysis
Radiation Therapy
Pemetrexed Disodium
Oxaliplatin
Doxorubicin Hydrochloride
Dexamethasone
Sorafenib Tosylate
Cetuximab
Irinotecan Hydrochloride
Vinorelbine Ditartrate



